Stripping away sector labels, two recent earnings transcripts—released Wednesday—present a common macro picture from different angles: the services economy remains resilient, but the drivers of that strength are shifting geographically and technologically. Elevance Health (ELV) reported a first quarter highlighted by significant adoption of its HealthOS platform, with evidence that digital transformation is increasingly central to operational efficiency. Otis Worldwide (OTIS), meanwhile, demonstrated how a robust global services base can offset equipment market weakness in China, with growth continuing mainly outside the Chinese market. Both reports came as macro rates continue to shape investor response: the 10-Year Treasury yield sits at 4.30% and the Fed Funds effective rate at 3.64%, according to FRED data this week.
Elevance Surpasses 88,000 Providers on HealthOS, Lifts Prior Auth Friction
Elevance's first quarter call centered on its effort to modernize managed care with digital tools. According to CEO Gail Boudreaux and management, the HealthOS digital platform now supports more than 88,000 care providers and over 1,200 provider organizations, enabling real-time prior authorization decisions when documentation is complete. Notably, Elevance has eliminated prior authorization on more than 400 outpatient procedures for high-performing providers, marking a quantifiable reduction in administrative friction.
Patient advocacy remains a focus: Over 6 million members were reached through Elevance’s advocacy solutions in Q1, which management cited as a differentiator in employer-based insurance competition, further noting a 95% satisfaction rate. The company’s executive team also highlighted continued investment in value-based care, such as the expanded Medicare Advantage oncology program, though they acknowledged continued headwinds from reimbursement pressures and regulatory adjustments tied to Medicaid and Medicare.
Stocks365 Take: Structural Strength Widens the Margin for Services Firms
The data points toward a bifurcation: managed care firms like Elevance are using platform scale to rework core cost structures, while services-based industrials draw margin durability from global installed bases. The macro backdrop—the 10Y-2Y yield spread at (with the 2-Year at 3.78%)—reflects neither crisis nor rampant growth, which supports steady operating environments for both.
Otis Modernization Orders Jump as China Remains a Drag
Otis’s Q2 results reflected stable service growth despite equipment cycle softness, especially in Asia. Organic service sales increased 4% in the quarter, and the maintenance portfolio reached 2.4 million units. Orders for modernization projects accelerated strongly, up 22%, while the backlog rose 16% at constant currency. New equipment orders declined 1% overall, pressured by China, but orders outside of China climbed 11%. To address weakness, Otis is targeting about $40 million in run-rate savings from its China transformation program, in addition to the UpLift initiative’s $200 million goal, with in-year targets of $70 million for UpLift and $20 million for China transformation. Tariff headwinds were revised down: expected 2025 tariff impact is now seen at $25 million to $35 million, about half of prior estimates. Otis returned capital to shareholders with $300 million in buybacks in Q2, bringing 2025 repurchases to $550 million year to date.
Key Risk: Macro Spreads and China’s Ongoing Weakness
Two markers will shape the evolution of these stories. First, continued stress in Chinese property markets could extend pressure on Otis’s new equipment business, although the service/modernization backlog provides a buffer. Second, Treasury yields near current levels—especially if the 10-Year approaches 4.50%—could raise capital costs and discount rates for managed care, pressuring Elevance’s liability matching. The macro yield curve at 51 basis points suggests a cautiously normalizing environment, not acute risk, and suits recurring-revenue service businesses. But any further macro shocks—either from rates or China—could quickly challenge the current resilience seen in both earnings calls.